Other Events ·
ABVC BioPharma postponed its previously announced distribution of ordinary shares in BioKey (Cayman), Inc., originally…
ABVCAbvc Biopharma, Inc.
ABVC BioPharma postponed its previously announced distribution of ordinary shares in BioKey (Cayman), Inc., originally scheduled for August 3, 2026. The delay allows the company additional time to finalize administrative, regulatory, and tax-related matters required to complete the transaction. The distribution ratio remains fixed at 0.169464 BioKey shares for each ABVC common share held as of the unchanged record date. The prior ex-dividend date is voided, with new dates to be announced once logistics are resolved. ABVC BioPharma operates in the biotechnology industry, focusing on drug discovery and development.